Chi Onyebuchi is a Director of Global Program Management at Takeda Pharmaceuticals. In this role, she actively leads the project planning efforts of the Global Product Team (GPT) in defining, implementing and driving the asset strategy and operational plan. Chi leads and manages the global, cross-functional and cross-divisional GPT through the project plan execution and holds teams to the highest standards for operational excellence in drug development and life cycle management. She currently supports multiple programs within Takeda’s Neuroscience Therapeutic Area Unit.
Chi is no stranger to project and program leadership or the pharmaceutical and Biotech industry. Prior to joining Takeda Pharmaceuticals in 2017, Chi worked in a diverse range of roles for companies including Biogen, Merck & Co, Inc., Schering Plough Corporation, the Cardiovascular Research Foundation and Memorial Sloan-Kettering Cancer Center. She has over 18 years of experience in clinical research operations and project/program management.
Chi holds a Bachelor of Arts degree in Political Science from Binghamton University, a Master of Public Health degree from New York University and is currently completing a PhD in Epidemiology at Walden University.